We provide you with 20 years of free, institutional-grade data for FMTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of FMTX. Explore the full financial landscape of FMTX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Forma Therapeutics Holdings, Inc(NASDAQ:FMTX) 
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatm...
Website: https://www.formatherapeutics.com/
Founded: 2007
Full Time Employees: 114 (May 2021)
CEO: Frank D. Lee
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about FMTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.